Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 1 hour agoIn June 2024 the FDA’s Vaccines and Related Biological Products Advisory Committee recommended the...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 7 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Health officials keep eye on ‘FLiRT’ COVID variants that could lead to fall surge
Cumberland Times-News· 6 days agoWith Maryland nearing 1.5 million reported cases of COVID-19 since the start of the pandemic,...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Moderna announces good results from trial of combo COVID / flu vaccine
Medical Xpress· 7 days agoThe phase 3 trial is only another step towards approval of the dual-purpose shot, which won't be...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
More than 150 rescued as hikers at Havasupai Falls report mysterious illness
The Arizona Republic· 3 days agoDozens of hikers reported feeling ill after visiting Havasupai Falls in early June, according to the...
COVID cases rising in L.A. County and California as new subvariants make mark
Los Angeles Times· 5 days agoCalifornia’s COVID-19 numbers are on the rise thanks in part to new subvariants, suggesting an...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 3 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...